The Most Connected Hospice Doctor in California: An Investigation into Medicare Fraud

Uncovering an Unprecedented Medical Anomaly

In a startling revelation that has sent shockwaves through the healthcare community, CBS News conducted an extensive investigation that uncovered what appears to be one of the most extraordinary cases of potential Medicare fraud in recent history. At the center of this investigation is Dr. Rajiv Bhuva, a Los Angeles County hospice physician whose name appeared on Medicare claims for an astounding nearly 2,800 patients across 126 different hospice facilities in just a single year. To put this into perspective, this would mean Dr. Bhuva would have had to see approximately eight patients every single day of the year, including weekends and holidays, scattered across more than a hundred different locations throughout the region. The sheer impossibility of providing genuine, quality care to this many patients across so many facilities raises serious questions about the legitimacy of these Medicare claims and points to what investigators believe may be a sophisticated fraud scheme exploiting the hospice care system.

The numbers alone tell a troubling story that defies medical logic and physical possibility. Hospice care, by its very nature, requires intimate, personal attention to patients in their final stages of life. These aren’t quick office visits or routine checkups; hospice physicians are expected to spend meaningful time with patients, assess their complex medical needs, coordinate with families, and work closely with interdisciplinary care teams. The average hospice doctor typically manages somewhere between 50 to 100 patients at any given time, which allows for the personalized attention and dignity that end-of-life care demands. Dr. Bhuva’s alleged patient load of nearly 2,800 across 126 facilities represents a volume that would be physically impossible for one physician to manage properly, even if they worked around the clock without sleep. This discovery has prompted federal investigators to take a closer look at not only Dr. Bhuva’s practice but also the systemic vulnerabilities in the hospice care industry that allow such schemes to flourish.

The Mechanics of Hospice Medicare Fraud

Understanding how this type of fraud operates requires examining the unique way Medicare reimburses hospice care providers. Unlike traditional fee-for-service medical care, hospice operates on a per-diem payment system, meaning that Medicare pays hospice providers a daily rate for each patient under their care, regardless of the actual services provided on any given day. This creates a perverse incentive structure where hospice companies profit more by enrolling more patients and keeping them enrolled longer, rather than focusing on the quality and appropriateness of care. To bill Medicare, hospices must have a physician certify that patients are terminally ill with a life expectancy of six months or less. This is where unscrupulous physicians like Dr. Bhuva allegedly come into play—by lending their medical license and signature to certify patients as hospice-eligible, often without actually examining them or verifying their terminal status.

The scheme typically works through what investigators call “rent-a-doc” arrangements, where hospices contract with physicians who are willing to sign off on patient certifications and paperwork in exchange for payment, regardless of whether they’ve actually provided any real medical services. These physicians may visit facilities sporadically or not at all, instead simply signing stacks of forms that allow the hospice to bill Medicare. Some physicians involved in these schemes have admitted to signing certification documents for patients they’ve never met, based solely on medical records provided by the hospice company. The financial incentives are substantial: hospice companies can generate millions of dollars in Medicare revenue, and the physicians receive lucrative consulting fees or per-signature payments that can amount to hundreds of thousands of dollars annually. Meanwhile, patients may be enrolled in hospice inappropriately, sometimes when they aren’t actually terminally ill, depriving them of potentially curative treatments and consuming resources meant for those genuinely in need of end-of-life care.

The Broader Pattern of Hospice Industry Abuse

Dr. Bhuva’s case, while extreme in its numbers, is unfortunately not an isolated incident but rather a symptom of widespread problems plaguing the hospice industry. Over the past two decades, hospice care in America has transformed from a primarily nonprofit, mission-driven service into an increasingly commercialized industry dominated by for-profit companies. This shift has brought with it a wave of fraud, abuse, and quality-of-care concerns that have cost taxpayers billions of dollars while potentially harming vulnerable patients in their final days. Federal audits and investigations have repeatedly found that significant percentages of hospice patients may not actually meet the criteria for hospice eligibility, suggesting systematic enrollment of patients who aren’t truly terminally ill. Some hospices have been caught aggressively recruiting patients from nursing homes, hospitals, and even public places, offering kickbacks to healthcare workers who refer patients, and using high-pressure tactics to convince families to enroll loved ones who may not be appropriate for hospice care.

The geographic pattern of hospice usage across the United States reveals troubling disparities that suggest fraud rather than legitimate variation in medical need. Certain regions, particularly areas of California, Texas, and Nevada, show hospice utilization rates dramatically higher than the national average, with some patients remaining in hospice care for years rather than months. Investigative reports have documented cases of patients going to Disneyland, running marathons, and even returning to work while supposedly under hospice care for terminal illnesses. The Centers for Medicare and Medicaid Services (CMS) has identified hospice fraud as a priority concern, but enforcement efforts have struggled to keep pace with the industry’s explosive growth. From 2000 to 2020, the number of hospice providers in the United States more than tripled, with much of that growth concentrated in for-profit companies that often prioritize revenue generation over patient care quality. This rapid expansion has created an environment where bad actors can operate with relative impunity, moving from one corporate entity to another when scrutiny increases, and exploiting regulatory loopholes that make prosecution difficult.

The Human Cost Behind the Numbers

While the financial dimensions of hospice fraud are staggering—potentially costing Medicare billions of dollars annually—the human toll is equally devastating and often overlooked. Patients who are inappropriately enrolled in hospice care are required to forgo curative treatments as a condition of receiving hospice benefits. This means individuals who might have recovered from their illnesses or lived significantly longer with appropriate treatment instead find themselves on a palliative care track, receiving only comfort measures while their underlying conditions progress untreated. Families trust that when a physician certifies their loved one as terminally ill, that assessment is based on careful medical evaluation and genuine expertise. When that certification is fraudulent—signed by a doctor who has never examined the patient or who is knowingly misrepresenting their condition—it represents a profound betrayal of that trust at one of life’s most vulnerable moments.

Beyond individual patient harm, this type of fraud corrodes the entire healthcare system’s integrity and diverts precious resources away from legitimate needs. Every dollar fraudulently claimed from Medicare is a dollar unavailable for genuine medical care, whether that’s hospice services for truly terminal patients, treatments for curable conditions, or preventive care that could keep people healthy. The hospice workers who are trying to provide compassionate, ethical end-of-life care find themselves competing against fraudulent operators who can undercut prices and over-promise services because they have no intention of actually delivering quality care. Families who have experienced genuine, appropriate hospice care for dying loved ones see the entire field tarnished by these scandals, creating skepticism and reluctance to utilize hospice services even when they would be truly beneficial. The medical professionals who maintain their integrity and refuse to participate in fraudulent schemes may find themselves at a competitive disadvantage against colleagues willing to compromise ethics for financial gain.

Regulatory Challenges and Enforcement Gaps

The persistence and scale of hospice fraud, exemplified by cases like Dr. Bhuva’s, expose significant weaknesses in the regulatory framework governing Medicare reimbursement and oversight. The Centers for Medicare and Medicaid Services, which administers the Medicare hospice benefit, operates with limited resources for proactive fraud detection and must balance access to care against fraud prevention. The agency relies heavily on retrospective audits and investigations that often identify problems years after the fraud has occurred, allowing bad actors to collect millions in improper payments before facing any consequences. The regulatory structure makes it difficult to take swift action against suspicious billing patterns; even when fraud is suspected, the legal process for excluding providers from Medicare or recovering improperly paid funds can take years, during which the fraudulent activity often continues.

Part of the challenge lies in the documentation requirements—or lack thereof—for hospice certification. While physicians are supposed to certify that patients have a terminal illness with a life expectancy of six months or less if the disease runs its normal course, this involves a degree of medical judgment that is inherently subjective. Fraudulent physicians exploit this ambiguity, arguing that their certifications represented legitimate medical opinions even when evidence suggests they spent little or no time actually evaluating patients. The ease of establishing new hospice companies also enables persistent fraud; when one hospice faces investigation or enforcement action, its operators can simply close that entity and open a new one under a different name, continuing the same fraudulent practices under fresh corporate cover. Federal and state authorities have called for reforms including more stringent pre-enrollment screening for new hospice providers, mandatory face-to-face physician examinations for hospice certification, better data analytics to identify suspicious billing patterns in real-time, and stronger penalties that serve as genuine deterrents rather than merely costs of doing business for fraudulent operators.

Moving Toward Accountability and Reform

The CBS News investigation into Dr. Bhuva and similar cases has catalyzed renewed attention to hospice fraud and sparked calls for comprehensive reform of the system. Lawmakers, patient advocates, and healthcare integrity professionals agree that protecting the Medicare hospice benefit requires a multi-faceted approach that addresses both individual bad actors and the systemic vulnerabilities they exploit. This includes strengthening physician accountability by tracking patterns across providers, making it harder for physicians to lend their licenses to multiple hospices without providing genuine medical oversight. Enhanced data analytics and artificial intelligence tools show promise for identifying impossible billing patterns—like one physician claiming to provide services to thousands of patients across dozens of facilities—before millions in fraudulent payments go out the door.

Perhaps most importantly, reform efforts must refocus the hospice industry on its original mission: providing dignified, compassionate care to people in the final chapters of their lives. This means supporting and incentivizing the ethical providers who do this difficult work with integrity, while aggressively pursuing and excluding those who see dying patients as nothing more than billing opportunities. For families facing end-of-life decisions for loved ones, it means having confidence that hospice recommendations are based on genuine medical need rather than financial opportunism. The case of Dr. Bhuva serves as a stark reminder that healthcare fraud isn’t a victimless crime of paperwork and billing codes—it affects real people at their most vulnerable moments, and society has both a fiscal and moral obligation to root it out and hold perpetrators accountable. As investigations continue and reforms are debated, the ultimate goal must be ensuring that America’s hospice system fulfills its promise of providing comfort, dignity, and appropriate care to those approaching life’s end, rather than serving as a vehicle for exploitation and fraud.